초록 ▼

Methods of sealing an injection site of a tissue are provided, where therapeutic agent has been injected into tissue, resulting in increased efficiency or agent uptake. Also provided are methods for delivering therapeutic agent to a tissue, which include injecting a therapeutic agent into a tissue a

Methods of sealing an injection site of a tissue are provided, where therapeutic agent has been injected into tissue, resulting in increased efficiency or agent uptake. Also provided are methods for delivering therapeutic agent to a tissue, which include injecting a therapeutic agent into a tissue and subsequently sealing the injection site, or engaging an injection device with the tissue for a sufficient period of time that sealing is not necessary to avoid leakage of the therapeutic agent. In one embodiment radio frequency cautery is used to seal the injection site upon needle removal from the tissue. In other embodiments, the injection site is sealed by resistance heating, laser heating or plugging the site with a solid plug or coagulating material at the site.

대표청구항 ▼

1. A method of inhibiting leakage of a therapeutic agent that has been injected into a target tissue comprising: injecting the therapeutic agent into the target tissue with an injection device; removing the injection device from the target tissue, wherein a track is created in the tissue upon re

1. A method of inhibiting leakage of a therapeutic agent that has been injected into a target tissue comprising: injecting the therapeutic agent into the target tissue with an injection device; removing the injection device from the target tissue, wherein a track is created in the tissue upon removal of the injection device; and applying a coagulating material at the mouth of the track to seal the mouth and to inhibit leakage of the therapeutic agent from the mouth. 2. The method of claim 1, wherein the coagulating material is a polymeric material or a monomeric material that is polymerized into a polymeric material. 3. The method of claim 2, wherein said polymeric material is selected from the group consisting of poly(oxyalkene) polymers and copolymers and blends with poly(alphahydroxy) acids, collagen, elastin, agarose, agar, hyaluronic acid, hyalobiuronic acid, heparin, cellulose, alginate, curdlan, chitin, chitosan, and derivatives thereof, cellulose acetate, carboxymethyl cellulose, hydroxymethyl cellulose, cellulose sulfate sodium salt, ethylcellulose, poly(acrilic acids), poly(acrylates), polyacrylamides, polyvinyl alcohols, polyethylene glycols, ethylene vinyl acetates, and amino containing polymers. 4. The method of claim 1, wherein the coagulating material is a non-polymeric material. 5. The method of claim 4, wherein the non-polymeric material is selected from the group consisting of sterols, cholesteryl esters, C12-C14fatty acids, C18-C3,mono-, di- and triacylglyciderides, sucrose fatty acid esters, sorbitan fatty acid esters, C16-C18fatty alcohols, esters of fatty alcohols, esters of fatty acids, anhydrides of fatty acids, phospholipids, sphingosine, spingomyelins, ceramides, glycosphingolipids, lanolin, lanolin alcohols, and derivatives, combinations, and mixtures thereof.